Cytosorbents (CTSO) Current Leases (2018 - 2026)
Cytosorbents' (CTSO) quarterly Current Leases came in at $565000.0 in Q1 2026, up 19.23% YoY from $473889.0 in Q1 2025, and up 4.44% on a QoQ basis from $541000.0 in Q4 2025.
Cytosorbents (CTSO) Current Leases (2018 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 9 years of Current Leases data on file, last reported at $565000.0 in Q1 2026.
- Quarterly Current Leases rose 19.23% year-over-year to $565000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $565000.0 (up 19.23% YoY) and the FY2025 annual result came in at $541000.0, up 19.43% from the prior year.
- Current Leases rose to $565000.0 in Q1 2026, from $541000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $565000.0 in Q1 2026 to a low of $108939.0 in Q4 2022.
- A 5-year average of $375806.6 and a median of $416861.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases sank 80.91% — and 2024, when it surged 268.59%.
- Tracing CTSO's Current Leases over 5 years: stood at $108939.0 in 2022, then surged by 242.98% to $373636.0 in 2023, then gained by 21.24% to $453000.0 in 2024, then advanced by 19.43% to $541000.0 in 2025, then advanced by 4.44% to $565000.0 in 2026.
- The last three Current Leases figures came in at $565000.0 (Q1 2026), $541000.0 (Q4 2025), and $518000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 589,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 589,000.00 |
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 541,000.00 |
| Sep 30, 2025 | 518,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 473,889.00 |
| Dec 31, 2024 | 453,000.00 |
| Sep 30, 2024 | 431,997.00 |
| Jun 30, 2024 | 412,067.00 |
| Mar 31, 2024 | 392,617.00 |
| Dec 31, 2023 | 373,636.00 |
| Sep 30, 2023 | 117,204.00 |
| Jun 30, 2023 | 114,382.00 |
| Mar 31, 2023 | 111,627.00 |
| Dec 31, 2022 | 108,939.00 |
| Sep 30, 2022 | 376,529.00 |
| Jun 30, 2022 | 416,861.00 |
| Mar 31, 2022 | 486,964.00 |
| Dec 31, 2021 | 570,566.00 |
| Sep 30, 2021 | 265,675.00 |